Log in to save to my catalogue

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic de...

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic de...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20668365

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi

About this item

Full title

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2008-04, Vol.105 (15), p.5868-5873

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Huntington's disease (HD) is a fatal, dominant neurodegenerative disease caused by a polyglutamine repeat expansion in exon 1 of the HD gene, which encodes the huntingtin protein. We and others have shown that RNAi is a candidate therapy for HD because expression of inhibitory RNAs targeting mutant human HD transgenes improved neuropathology and be...

Alternative Titles

Full title

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_20668365

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20668365

Other Identifiers

ISSN

0027-8424,1091-6490

E-ISSN

1091-6490

DOI

10.1073/pnas.0801775105

How to access this item